Answer
Trumenba is indicated from 10 years of age for active immunisation to prevent invasive disease caused by Neisseria meningitidis serogroup B, in accordance with official recommendations.
Sources for this answer
- Trumenba suspension for injection in pre-filled syringePfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 17Document updated
Sources checked